Search research articles
Contact Us
Filters
Showing results (41-50 of 118) with videos related to
Page
of 12
Sort By:
BJU International
|
January 23, 2016
Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model
Boris Gershman, Naoki Takahashi, Daniel M Moreira, et al.
Urologic Oncology
|
June 4, 2024
Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis
Cameron J Britton, Jack R Andrews, Christopher J D Wallis, et al.
European Urology
|
September 28, 2016
Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis
Boris Gershman, R Houston Thompson, Daniel M Moreira, et al.
Urology
|
October 13, 2023
Percutaneous Image Guided Cryoablation of Adrenal Metastases From Renal Cell Carcinoma: A Single Institution Review
Kelly C Harper, Thomas D Atwell, Blake A Kassmeyer, et al.
European Urology
|
January 3, 2013
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors
Dharam Kaushik, Simon P Kim, M Adam Childs, et al.
Urologic Oncology
|
September 20, 2018
Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era
Timothy D Lyon, Boris Gershman, Paras H Shah, et al.
The Journal of Urology
|
September 28, 2011
Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort
Simon P Kim, Nilay D Shah, Christopher J Weight, et al.
Urologic Oncology
|
November 26, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy
Vignesh T Packiam, Mark D Tyson Ii, Matvey Tsivian, et al.
Urologic Oncology
|
November 9, 2021
Collecting duct carcinoma: A single-institution retrospective study
Zhuoer Xie, Siddhartha Yadav, Christine M Lohse, et al.
The Journal of Urology
|
September 6, 2022
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model
Vidit Sharma, Kevin M Wymer, Daniel D Joyce, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 118) with videos related to
Sort By:
Page
of 12
BJU International
|
January 23, 2016
Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model
Boris Gershman, Naoki Takahashi, Daniel M Moreira, et al.
Urologic Oncology
|
June 4, 2024
Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis
Cameron J Britton, Jack R Andrews, Christopher J D Wallis, et al.
European Urology
|
September 28, 2016
Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis
Boris Gershman, R Houston Thompson, Daniel M Moreira, et al.
Urology
|
October 13, 2023
Percutaneous Image Guided Cryoablation of Adrenal Metastases From Renal Cell Carcinoma: A Single Institution Review
Kelly C Harper, Thomas D Atwell, Blake A Kassmeyer, et al.
European Urology
|
January 3, 2013
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors
Dharam Kaushik, Simon P Kim, M Adam Childs, et al.
Urologic Oncology
|
September 20, 2018
Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era
Timothy D Lyon, Boris Gershman, Paras H Shah, et al.
The Journal of Urology
|
September 28, 2011
Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort
Simon P Kim, Nilay D Shah, Christopher J Weight, et al.
Urologic Oncology
|
November 26, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy
Vignesh T Packiam, Mark D Tyson Ii, Matvey Tsivian, et al.
Urologic Oncology
|
November 9, 2021
Collecting duct carcinoma: A single-institution retrospective study
Zhuoer Xie, Siddhartha Yadav, Christine M Lohse, et al.
The Journal of Urology
|
September 6, 2022
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model
Vidit Sharma, Kevin M Wymer, Daniel D Joyce, et al.
Page
of 12